1. Home
  2. ILMN vs RMD Comparison

ILMN vs RMD Comparison

Compare ILMN & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Illumina Inc.

ILMN

Illumina Inc.

SELL

Current Price

$202.21

Market Cap

37.0B

Sector

Health Care

ML Signal

SELL

Logo ResMed Inc.

RMD

ResMed Inc.

SELL

Current Price

$239.10

Market Cap

33.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ILMN
RMD
Founded
1998
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.0B
33.6B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
ILMN
RMD
Price
$202.21
$239.10
Analyst Decision
Buy
Buy
Analyst Count
21
20
Target Price
$261.45
★ $264.33
AVG Volume (30 Days)
★ 2.1M
1.3M
Earning Date
10-29-2026
10-29-2026
Dividend Yield
N/A
★ 1.11%
EPS Growth
★ 170.87
9.67
EPS
★ 3.65
2.92
Revenue
★ $4,343,000,000.00
$2,957,013,000.00
Revenue This Year
$6.61
$3.12
Revenue Next Year
$7.00
$6.43
P/E Ratio
★ $54.19
$81.62
Revenue Growth
N/A
★ 13.44
52 Week Low
$112.65
$180.27
52 Week High
$309.35
$277.67

Technical Indicators

Market Signals
Indicator
ILMN
RMD
Relative Strength Index (RSI) 33.96 51.20
Support Level $200.01 $218.45
Resistance Level $201.83 $257.89
Average True Range (ATR) 12.45 7.67
MACD -4.42 -0.69
Stochastic Oscillator 4.20 51.62

Price Performance

Historical Comparison
ILMN
RMD

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: